DESIGN, SYNTHESIS AND IN-VITRO EVALUATION OF ATP-COMPETITIVE INHIBITORS OF AURORA KINASE-A USING STRUCTURE-BASED DRUG DESIGN (SBDD)

被引：0
|
作者：
Abdullah, Omeima Alhaj
Mehanna, Ahmed
机构：
来源：
FASEB JOURNAL | 2018年 / 32卷 / 01期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
lb632
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Structure-based design, synthesis, and biological evaluation of potent and selective macrocyclic checkpoint kinase 1 inhibitors
    Tao, Zhi-Fu
    Wang, Le
    Stewart, Kent D.
    Chen, Zehan
    Gu, Wendy
    Bui, Mai-Ha
    Merta, Philip
    Zhang, Haiying
    Kovar, Peter
    Johnson, Eric
    Park, Chang
    Judge, Russell
    Rosenberg, Saul
    Sowin, Thomas
    Lin, Nan-Horng
    JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (07) : 1514 - 1527
  • [22] Homology structure-based design, synthesis and biological evaluation of a series of novel Axl and Mer kinase inhibitors
    Mollard, Alexis
    Warner, Steven L.
    Call, Lee
    Wade, Mark
    Bearss, Jared
    Verma, Anupam
    Yang, Mei
    Sharma, Sunil
    Bearss, David J.
    Vankayalapati, Hariprasad
    CANCER RESEARCH, 2011, 71
  • [23] Structure-based design, synthesis and biochemical evaluation of reversible competitive inhibitors for Tissue Factor/Factor VII-a
    Clement, Cristina C.
    Philipp, Manfred
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [24] Latest developments in crystallography and structure-based design of protein kinase inhibitors as drug candidates
    Williams, DH
    Mitchell, T
    CURRENT OPINION IN PHARMACOLOGY, 2002, 2 (05) : 567 - 573
  • [25] Structure-based drug design of novel and highly potent pyruvate dehydrogenase kinase inhibitors
    Bessho, Yuki
    Akaki, Tatsuo
    Hara, Yoshinori
    Yamakawa, Maki
    Obika, Shingo
    Mori, Genki
    Ubukata, Minoru
    Yasue, Katsutaka
    Nakane, Yoshitomi
    Terasako, Yasuo
    Orita, Takuya
    Doi, Satoki
    Iwanaga, Tomoko
    Fujishima, Ayumi
    Adachi, Tsuyoshi
    Ueno, Hiroshi
    Motomura, Takahisa
    BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 52
  • [26] Structure-based drug design and AutoDock study of potential protein tyrosine kinase inhibitors
    Ali, Hamed Ismail
    Nagamatsu, Tomofumi
    Akaho, Eiichi
    BIOINFORMATION, 2011, 5 (09) : 368 - 374
  • [27] Structure-based drug design and the evaluation of irreversible HCV-protease inhibitors
    Qiao, Lixin
    Niu, Deqiang
    Zhu, Zhendong
    Labenski, Matt
    Hagel, Margit
    St Martin, Thia
    Sheet, Michael
    Bernard, Hugues
    Nacht, Mariana
    Westlin, Willian
    Petter, Russell
    Singh, Juswinder
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
  • [28] ITERATIVE PROTEIN STRUCTURE-BASED DRUG DESIGN AND SYNTHESIS OF HIV PROTEASE INHIBITORS
    KALISH, V
    KALDOR, S
    SHETTY, B
    TATLOCK, J
    DAVIES, J
    HAMMOND, M
    DRESSMAN, B
    FRITZ, J
    APPELT, K
    REICH, S
    MUSICK, L
    WU, BW
    SU, K
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1995, 30 : S201 - S214
  • [29] PROTEIN STRUCTURE-BASED DRUG DESIGN AND SYNTHESIS OF NONPEPTIDIC HIV PROTEASE INHIBITORS
    TATLOCK, JH
    KALISH, VJ
    DAVIES, J
    APPELT, K
    REICH, S
    MUSICK, L
    WU, B
    KALDOR, S
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 209 : 120 - MEDI
  • [30] PROTEIN STRUCTURE-BASED DRUG DESIGN AND SYNTHESIS OF NONPEPTIDIC HIV PROTEASE INHIBITORS
    GAJDA, C
    DOMAGALA, J
    TAIT, B
    HAGEN, S
    TUMINO, P
    FERGUSON, D
    PAVLOVSKY, A
    RUBIN, J
    LUNNEY, E
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 210 : 21 - MEDI
12345